Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
IntegReview IRB was acquired by Advarra
Shanghai Youlin Pharmaceutical Technology closed a $14.9mm round of funding, led by Cenova Ventures
Outcomes4me closed a $4.7mm round of funding, led by Asset Management Ventures